About 5-hydroxytryptamine receptor 2B
5-hydroxytryptamine receptor 2B (HTR2B) is a protein
from Homo sapiens identified by UniProt accession
P41595, 481 residues long.
MolForge cross-references it against 0 known binders and
133 disease associations.
Target properties
| Protein name | 5-hydroxytryptamine receptor 2B |
| UniProt accession | P41595 |
| Gene | HTR2B |
| Organism | Homo sapiens |
| Length | 481 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (16)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (133)
Diseases linked to this target (Open Targets).
- hemorrhage · score 0.60
- schizophrenia · score 0.59
- schizoaffective disorder · score 0.50
- post operative nausea and vomiting · score 0.47
- psychosis · score 0.46
- unipolar depression · score 0.46
- depressive disorder · score 0.43
- migraine disorder · score 0.37
- mental or behavioural disorder · score 0.37
- obesity · score 0.37
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P41595-F1 | alphafold | PREDICTED | 71.54 | — |
Amino-acid sequence (481 residues)
MALSYRVSEL QSTIPEHILQ STFVHVISSN WSGLQTESIP EEMKQIVEEQ GNKLHWAALL ILMVIIPTIG GNTLVILAVS LEKKLQYATN YFLMSLAVAD LLVGLFVMPI ALLTIMFEAM WPLPLVLCPA WLFLDVLFST ASIMHLCAIS VDRYIAIKKP IQANQYNSRA TAFIKITVVW LISIGIAIPV PIKGIETDVD NPNNITCVLT KERFGDFMLF GSLAAFFTPL AIMIVTYFLT IHALQKKAYL VKNKPPQRLT WLTVSTVFQR DETPCSSPEK VAMLDGSRKD KALPNSGDET LMRRTSTIGK KSVQTISNEQ RASKVLGIVF FLFLLMWCPF FITNITLVLC DSCNQTTLQM LLEIFVWIGY VSSGVNPLVY TLFNKTFRDA FGRYITCNYR ATKSVKTLRK RSSKIYFRNP MAENSKFFKK HGIRNGINPA MYQSPMRLRS STIQSSSIIL LDTLLLTENE GDKTEEQVSY V
Explore 5-hydroxytryptamine receptor 2B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets